Time-Dependent Vascular Effects of Endocannabinoids Mediated by Peroxisome Proliferator-Activated Receptor Gamma (PPAR)
Figure 3
The effects of the PPARγ
antagonist GW9662 (1 μM,
(a), and (b)) and the protein synthesis inhibitor, cycloheximide (10 μM, (c), and (d)) on vasorelaxation to anandamide and
NADA. Data are given as means with
error bars representing SEM.
